Neurostyle Launch Event
Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company (subsidiary company of Actoverco) announced that Neurostyle, produced in tablet form by Nexus specialists, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections. Nexus has distributed new products in the form of tablets, soft gels, and effervescent tablets, and […]
Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement
Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company, announced that this supplement, produced in tablet form by Nexus specialists from the Actoverco Pharmaceutical Group, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections. She stated that the ingredients used in the Neurostyle supplement include B vitamins, and […]
Actoverco launches diabetes drug “Trytis”
According to Actoverco pharmaceutical Group; Trytis is going to be launched and released on the market soon. Trytis is an oral combination diabetes medication used to control blood sugar in people with type 2 diabetes. This drug is a combination of metformin, empagliflozin and linagliptin, which reduces blood sugar with three different mechanisms. Approximately […]
“International Labour Day”
Message from Nahale Naraghi On the occasion of “International Labour Day” International Labour Day is a valuable opportunity to honor and appreciate the selfless efforts and services of the honorable and hardworking workers. 1st May is “International Labour Day”. It is a valuable opportunity to honor and appreciate the selfless efforts and services of the […]
Actoverco host a Futsal tournament!
“Together for health” Futsal tournament for active athletes in the medical and therapeutic fields with the slogan “Together for health” will be held by Actoverco pharmaceutical group in June. According to the public relations report of Actoverco pharmaceutical group; futsal tournament for men with the slogan “Together for health” will be held at […]
Bright future for pharmaceutical industry in Iran!
Bright future for pharmaceutical industry in Iran! By Nahaleh Naraqi The future of the pharmaceutical industry in Iran is bright. Although Iran’s economy is going through difficult years, this industry has managed to pass the year 2023 with better conditions in many indicators. Obstacles and economic fluctuations and infrastructural problems that exist especially in […]
Message from Ms. Nahaleh Naraghi on the occasion of Health Week
Message from Ms. Nahaleh Naraghi on the occasion of Health Week “National Health Week”, a reminder of a serious social responsibility From the 21st till 27th of April is celebrated as “National Health Week” in Iran. The slogan of this year’s national health week is “family health and popularization of health”. “National Health Week” serves […]
A Message on the Occasion of Nowruz!
Nahaleh Naraghi congratulated Nowroz! As the vibrant colors of spring paint the world anew, we at Actoverco Group extend our heartfelt Nowruz greetings to you and your loved ones. Nowruz, the Persian New Year, marks the beginning of a season filled with hope, joy, and rejuvenation. It is a time when we celebrate the beauty […]
Production of two new blood pressure medicines in the country
Specialists at a pharmaceutical company have developed two new drugs to treat high blood pressure, a condition that affects approximately 32 million Iranians to varying degrees. The CEO of Actoverco pharmaceutical group, Reza Karimi Mostofi, reported that the specialists of his group have successfully provided the blood pressure medication Telmyc-H to patients in Iran. Telmyc-H […]
Merck, Actover’s reliable partner in the transfer of the most advanced pharmaceutical technologies to Iran
Merck, a German company, is one of the oldest manufacturers of drugs, chemicals, and health materials globally, and it is a leading name in the research and development (R&D) field in these sectors. The company exports its products to over 60 countries worldwide and is renowned for its innovative technology in the pharmaceutical industry. Merck’s […]